Article View: bit.listserv.mdphd-l
Article #339Drug companies and residents
From: Ron Wright
Date: Mon, 31 Jan 1994 02:57
Date: Mon, 31 Jan 1994 02:57
37 lines
2820 bytes
2820 bytes
I was wondering if any of you you had references to materials
about the role of drug companies on doctors, particularly
residents.
Having finished my MD-PhD program, I am a psychiatry resident at
Indiana University (and a postdoc in Sociology). Last week, I
went to our weekly resident's meeting where problems with call,
courses, and whatever are discussed. Some 15 minutes into the
meeting, and withmore business to come, the floor was turned over
to the Prozac reps who began a very slick and persuasive
presentation, but loaded with inuendo ("Isn't it interesting that
they didn't seek that indication with the FDA; perhaps their data
just don't support it like ours do; we just don't know....but
isn't it interesting...") or misdirection (20 minutes into the
"educational program discussing various seritonin agents" she
says "Now for the commercial -- you knew this was coming!").
I don't like being forced to sit thru such farces (I walked out
after 30 minutes). But what disturbs me most is that essentially
all of the other residents see no problem with this: Well, they
did pay for our lunch; the least we can do is be polite enough to
listen, and anyway I'm leaning things that help me perscribe
better.
Do you know of any way to reach people like this? I once heard
that some Nadar group had a video, but I don't know who it was
directed to or how to get ahold of it. I have done a MedLine
search and am tracking down some of the articles I found there.
Any suggestions?
Ron
--
Ron Wright Department of Sociology
Internet: rowright@indiana.edu 744 Ballantine Hall
Bitnet: ROWRIGHT@Indiana Indiana University
Phone: 812/333-5679 Bloomington, IN 47405
Technical Details
Message-ID:
<MDPHD-L%94013021593960@UBVM.CC.BUFFALO.EDU>Path:
arc1-ca.pugleaf.net!gmd.de!newsserver.jvnc.net!howland.reston.ans.net!paladin.american.edu!auvm!BRONZE.UCS.INDIANA.EDU!rowrightShow Full Headers
Complete Article Headers
X-Google-Language: ENGLISH,ASCII-7-bit
X-Google-Thread: 1028bb,fbead74b80ce672b
X-Google-Attributes: gid1028bb,public
X-Google-ArrivalTime: 1994-01-31 14:57:18 PST
Path: arc1-ca.pugleaf.net!gmd.de!newsserver.jvnc.net!howland.reston.ans.net!paladin.american.edu!auvm!BRONZE.UCS.INDIANA.EDU!rowright
Comments: Gated by NETNEWS@AUVM.AMERICAN.EDU
Newsgroups: bit.listserv.mdphd-l
Return-Path: <@AUVM.AMERICAN.EDU,
@UBVM.CC.BUFFALO.EDU:owner-mdphd-l@UBVM.CC.BUFFALO.EDU>
Return-Path: <@UBVM.CC.BUFFALO.EDU:rowright@BRONZE.UCS.INDIANA.EDU>
Mime-Version: 1.0
Content-Type: text/plain; charset=US-ASCII
Content-Transfer-Encoding: 7bit
Content-Length: 1798
Message-ID: <MDPHD-L%94013021593960@UBVM.CC.BUFFALO.EDU>
Date: Sun, 30 Jan 1994 21:57:54 -0500
Sender: Dual Degree Programs Discussion List <MDPHD-L@UBVM.BITNET>
From: Ron Wright <rowright@BRONZE.UCS.INDIANA.EDU>
Subject: Drug companies and residents
In-Reply-To: <no.id> from "MDPhD-L" at Jan 15, 94 02:23:58 am
Lines: 36